33 year old primi with 38 weeks of gestation, k /c/o Hypothyroidism on treatment controlled , now with decreased fetal movement since 2 days , NST was done , USH and uterine Doppler done , it was normal. Now the fetal movements are normal. Tell me the next steps to be done , should we wait or do induction
Reading File
Finding Sources
Finding Sources
Searching PubMed
hypothyroidism pregnancy induction labor timing
Searching PubMed
decreased fetal movement management NST normal
Finding Sources
Finding Sources
Searching PubMed
hypothyroidism pregnancy outcomes stillbirth
Searching PubMed
"reduced fetal movement" management antepartum surveillance
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Searching the Web
hypothyroidism controlled pregnancy 38 weeks induction timing ACOG guidelines 2024
Finding Sources
Searching the Web
RCOG ACOG decreased fetal movement management guideline 2024 induction delivery
Reading Web Page
reduced fetal movement management induction high risk 38 39 weeks
Searching the Web
hypothyroidism controlled 38 weeks labor induction timing SMFM ACOG 2023 2024
Now I have enough information to give a thorough, structured clinical answer.
Clinical Assessment and Next Steps
Patient Summary: 33-year-old primigravida, 38 weeks, known hypothyroidism on controlled treatment, presented with decreased fetal movements (DFM) x 2 days - now resolved. NST reactive, ultrasound (including Doppler and uterine Doppler) normal.
Step 1: Current Status - What Does "Normal" Mean Here?
The reassuring findings are:
- Reactive NST - negative predictive value for fetal death within 1 week is >99.8% (Textbook of Family Medicine; Creasy & Resnik's Maternal-Fetal Medicine)
- Normal AFI / ultrasound - rules out oligohydramnios, placental insufficiency, FGR
- Normal uterine Doppler - no evidence of uteroplacental insufficiency
- Fetal movements now normal
This is currently reassuring. However, the underlying scenario requires careful individualised management because:
- The pregnancy is high risk (hypothyroidism + episode of DFM)
- She is a primigravida at 38 weeks
- DFM itself (even when resolved) is an independent risk factor for stillbirth and FGR
Step 2: Immediate Investigations to Complete
Even with a normal NST and ultrasound, the following should be done now (if not already):
| Investigation | Rationale |
|---|---|
| Full biophysical profile (BPP) | NST alone has lower sensitivity; adding BPP variables improves detection of fetal compromise. BPP score 8-10 is reassuring |
| Fetal weight estimation (EFW) + growth chart | Rule out FGR - a significant cause of DFM, and associated with hypothyroidism |
| Umbilical artery Doppler | If not specifically done - rules out elevated placental resistance. You mentioned uterine Doppler was normal, but umbilical artery Doppler is the more relevant vessel for fetal surveillance |
| TSH / Free T4 | Confirm thyroid control is adequate - uncontrolled hypothyroidism increases risk of placental dysfunction and stillbirth (ACOG PB 223) |
| Maternal kick chart / formal fetal movement diary | Continued active monitoring from today |
| CTG for 1-2 hours (if not done already as part of NST) | Ensure no decelerations, adequate variability, reactivity |
Step 3: To Induce or Wait? - Clinical Decision Framework
Arguments FOR induction NOW (at 38 weeks):
- Hypothyroidism (even treated) is associated with increased risk of stillbirth, placental abruption, preterm birth, and FGR. A 2023 study (PMID 36414887) confirmed maternal hypothyroidism is associated with adverse pregnancy outcomes including placental complications.
- DFM is an independent risk marker for stillbirth, even when initial assessment is reassuring. RCOG Green-top Guideline 57 notes that women presenting on 2+ occasions with RFM have nearly double the risk of poor perinatal outcome (OR 1.92).
- At 38 weeks, fetal lung maturity is achieved - neonatal risk from induction is low
- The ARRIVE trial (NEJM 2018) showed that elective induction at 39 weeks in low-risk pregnancies did NOT increase caesarean rates and reduced hypertensive complications - this supports the safety of early term induction
- This patient has multiple convergent risk factors: advanced maternal age (33 - borderline), primigravida, endocrine disorder, prior DFM
Arguments for EXPECTANT MANAGEMENT with intensified surveillance:
- The current assessment is fully reassuring (reactive NST, normal AFI, normal Doppler, movement restored)
- Hypothyroidism is controlled - if TSH is in range, the thyroid risk is significantly mitigated
- RCOG GTG-57 states that induction decision when CTG/growth/liquor are normal must be made after consultant-led individualised counselling
- The ACOG does not mandate induction at 38 weeks for controlled hypothyroidism
The Balanced Answer: Strongly consider induction at 38+0 to 39+0 weeks
Given the combination of:
- Controlled hypothyroidism (a recognised high-risk condition)
- Recent DFM episode
- Primigravida
- 38 completed weeks (term, safe for delivery)
Most guidelines and clinical practice support induction at 38-39 weeks rather than expectant management beyond 39 weeks. The risk-benefit favours delivery. Waiting beyond 39 weeks is not advisable in this clinical profile.
Step 4: Protocol for Next 24-72 Hours
If you choose to proceed with induction (recommended approach):
- Bishop score assessment - if unfavourable (score < 6), start cervical ripening:
- Dinoprostone (PGE2) gel/insert, or
- Foley catheter balloon for mechanical ripening
- Continuous CTG in labour (given high-risk status)
- Active management of third stage
- Paediatric/neonatology team notification (thyroid history)
- Check neonatal TSH at birth (maternal hypothyroidism can rarely affect neonatal thyroid function)
If you choose to continue expectant management:
- Twice-weekly NST + AFI (modified BPP) from now
- Repeat full BPP + growth scan every 2 weeks (or sooner if any new DFM)
- Strict kick count - Cardiff count-to-10 method; return immediately if <10 movements in 12 hours
- Repeat TSH - ensure control is adequate
- Hard stop at 39 weeks - induction regardless of fetal wellbeing
- If DFM recurs even once more, go straight to induction
Summary Decision Table
| Factor | Weight | Recommendation |
|---|---|---|
| Hypothyroidism (controlled) | Moderate risk | Induction by 39 weeks |
| DFM episode (resolved) | High risk signal | Induction preferred |
| Reactive NST + normal Doppler | Reassuring | Safe to wait 24-48h if Bishop unfavourable |
| 38 completed weeks, primigravida | Term, cervix may be unfavourable | Cervical ripening + induction |
| Normal movement now | Reassuring | Can allow 24-48h cervical ripening |
Bottom line: In a primigravida with controlled hypothyroidism who has just had a resolved episode of DFM at 38 weeks - the evidence and guidelines support induction of labour within the next 48-72 hours, ideally after confirming BPP score and verifying TSH control. Do not allow the pregnancy to continue beyond 39 weeks. Induction is the safer, guideline-consistent choice here.
Sources: Creasy & Resnik's Maternal-Fetal Medicine; RCOG Green-top Guideline No. 57 (Reduced Fetal Movements, updated April 2025); ACOG Practice Bulletin 223 (Thyroid Disease in Pregnancy); Knøsgaard et al., Clin Endocrinol 2023 [PMID 36414887]
This is a shared conversation. Sign in to Orris to start your own chat.